Examkin

Question

Difficulty: MediumOrdering Laboratory Tests

A 61-year-old woman is evaluated in the hospital due to an acute drop in her platelet count. She was admitted 5 days ago for a proximal right lower extremity deep vein thrombosis and was immediately started on a continuous intravenous unfractionated heparin infusion. On admission, her platelet count was 310,000/μL310,000/\mu \text{L}. Today's routine complete blood count reveals a platelet count of 140,000/μL140,000/\mu \text{L}. Her hemoglobin is 13.1 g/dL13.1 \text{ g/dL} and leukocyte count is 8,200/μL8,200/\mu \text{L}. The patient reports no hematuria, melena, or mucosal bleeding. Physical examination is unremarkable with no evidence of petechiae or purpura. The clinical team suspects heparin-induced thrombocytopenia, discontinues the unfractionated heparin, and initiates an argatroban infusion. Which of the following is the most appropriate next step in laboratory evaluation to support this diagnosis?

  1. Platelet factor 4-heparin antibody enzyme-linked immunosorbent assayAnswer
  2. B
    Serotonin release assay
  3. C
    Mixing study with normal plasma
  4. D
    ADAMTS13 activity assay
  5. E
    Antiphospholipid antibody panel

Answer

Platelet factor 4-heparin antibody enzyme-linked immunosorbent assay
The correct answer is the Platelet factor 4-heparin antibody enzyme-linked immunosorbent assay (ELISA). This patient's clinical presentation—a greater than 50%50\% drop in platelet count occurring 5 to 10 days after the initiation of unfractionated heparin—is classic for heparin-induced thrombocytopenia (HIT). Once HIT is clinically suspected (e.g., intermediate to high 4T score) and all heparin products are discontinued in favor of a non-heparin anticoagulant, the diagnosis must be confirmed using a sequential laboratory algorithm. The first step in this algorithm is ordering a highly sensitive screening immunoassay, typically the PF4-heparin antibody ELISA. Because of its high negative predictive value, a negative ELISA effectively rules out HIT. If the ELISA is positive, the diagnosis is typically confirmed using a highly specific functional test.

Step-by-Step Solution

1
Evaluate the timeline and magnitude of the platelet drop.
The patient's platelets dropped by more than 50%50\% (from 310,000/μL310,000/\mu \text{L} to 140,000/μL140,000/\mu \text{L}) exactly 5 days after initiating unfractionated heparin.
This specific temporal relationship and degree of thrombocytopenia yield a high 4T score, indicating a high clinical probability of heparin-induced thrombocytopenia (HIT).
2
Identify the immediate management steps taken.
Heparin was discontinued and a direct thrombin inhibitor (argatroban) was appropriately started.
Prompt cessation of heparin and initiation of non-heparin anticoagulation is required to prevent paradoxical thrombosis while awaiting confirmatory laboratory testing.
3
Determine the appropriate stepwise diagnostic laboratory algorithm.
An initial screening immunoassay (PF4-heparin ELISA) is selected as the next test.
Diagnostic guidelines mandate using a highly sensitive screening immunoassay first. Only if this is positive or indeterminate should a highly specific functional assay be performed.

Key Concept

The diagnosis of heparin-induced thrombocytopenia (HIT) requires a stepwise laboratory approach, beginning with a highly sensitive screening test (PF4-heparin antibody ELISA) followed by a highly specific functional confirmatory test (Serotonin release assay) if the initial screen is positive.
Estimated Time:1m 0s
Rate this question

Topics

Ordering Laboratory Tests

More questions from this topic